Caspase-12 and the inflammatory response to Yersinia pestis

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Ferwerda, Bart ^a   McCall, Matthew B B ^a   de Vries, Maaike C ^b   Hopman, Joost ^a   Maiga, Boubacar ^c   Dolo, Amagana ^c   Doumbo, Ogobara ^c   Daou, Modibo ^c   de Jong, Dirk ^a   Joosten, Leo A B ^a   Tissingh, Rudi A ^b   Reubsaet, Frans A G ^b   Sauerwein, Robert ^a   van der Meer, Jos W M ^a   van der Ven, André J A M ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12; CASPASE RECRUITMENT DOMAIN PROTEIN 15; TOLL LIKE RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; NOD2 PROTEIN, HUMAN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RIPK2 PROTEIN, HUMAN;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOMODULATION; INFLAMMATION; NONHUMAN; NORMAL HUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; YERSINIA PESTIS; GENE EXPRESSION REGULATION; INNATE IMMUNITY; MALI; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SEPSIS; YERSINIA INFECTION;

YERSINIA; YERSINIA PESTIS;

CASPASE 12; CYTOKINES; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-1BETA; MALI; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SEPSIS; YERSINIA INFECTIONS; YERSINIA PESTIS;

EID: 70149099163     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006870     Document Type: Article

References (30)

1. Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384: 201-232.
2. Martinon F, Tschopp J (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22.
3. Nadiri A, Wolinski MK, Saleh M (2006) The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. J Immunol 177: 4239-4245.
4. Fischer H, Koenig U, Eckhart L, Tschachler E (2002) Human caspase 12 has acquired deletrious mutations. Biochemical and Biophysical Research Communications 293: 722-726.
5. Kachapati K, O'Brien TR, Bergeron J, Zhang M, Dean M (2006) Population distribution of the functional caspase-12 allele. Hum.Mutat 27: 975.
6. Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, et al. (2006) Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet 78: 659-670.
7. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98-103.
8. Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol.Lett 85: 85-95.
9. Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343: 338-344.
10. Li P, Allen H, Banerjee S, Franklin S, Herzog L, et al. (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80: 401-411.
11. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, et al. (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429: 75-79.
12. Scott AM, Saleh M (2007) The inflammatory caspases: guardians against infections and sepsis. Cell Death.Differ 14: 23-31.
13. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
14. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
15. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, et al. (2006) Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440: 1064-1068.
16. Wang X, Grus WE, Zhang J (2006) Gene losses during human origins. PLoS Biol 4: e52.
17. LeBlanc PM, Yeretssian G, Rutherford N, Doiron K, Nadiri A, et al. (2008) Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 3: 146-157.
18. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, et al. (1999) Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U.S.A 96: 14043-14048.
19. Sing A, Tvardovskaia N, Rost D, Kirschning CJ, Wagner H, et al. (2003) Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int J Med Microbiol 293: 341-348.
20. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, et al. (2006) Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7: 1066-1073.
21. Cornelis GR (2002) The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol 3: 742-752.
22. Schotte P, Denecker G, Van Den BA, Vandenabeele P, Cornelis GR, et al. (2004) Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta. J Biol Chem 279: 25134-25142.
23. Levasseur A, Orlando L, Bailly X, Milinkovitch MC, Danchin EG, et al. (2007) Conceptual bases for quantifying the role of the environment on gene evolution: the participation of positive selection and neutral evolution. Biol Rev Camb Philos Soc 82: 551-572.
24. Eckhart L, Ballaun C, Hermann M, VandeBerg JL, Sipos W, et al. (2008) Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol Biol Evol 25: 831-841.
25. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P (2002) Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 9: 358-361.
26. O'Brien TR, Kachapati K, Zhang M, Bergeron J, Edlin BR, et al. (2007) HCV infection clearance with functional or non-functional caspase-12. Scand J Gastroenterol 42: 416-417.
27. Dolo A, Modiano D, Maiga B, Daou M, Dolo G, et al. (2005) Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am J Trop Med Hyg 72: 243-248.
28. Netea MG, Ferwerda G, de Jong DJ, Girardin SE, Kullberg BJ, et al. (2005) NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth J Med 63: 305-308.
29. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, et al. (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69: 1477-1482.
30. Grebenchtchikov N, van der Ven-Jongekrijg J, Pesman GJ, Geurts-Moespot A, van der Meer JW, et al. (2005) Development of a sensitive ELISA for the quantification of human tumour necrosis factor-alpha using 4 polyclonal antibodies. Eur Cytokine Netw 16: 215-222.